NCT02522611 2026-04-13
Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
National Institutes of Health Clinical Center (CC)
Phase 1/2 Not yet recruiting
National Institutes of Health Clinical Center (CC)
Middle East University
Qinghai Red Cross Hospital
3D Medicines
Bilecik Seyh Edebali Universitesi
Taian Cancer Hospital
National and Kapodistrian University of Athens
Mersin University
Hanoi Medical University
National Cancer Institute, Egypt